Neurizon inks $1.5M loan against R&D Tax Rebate
Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
ILF | fair value? | 02/08/12 | 1 | 1.7K | |||
|
|||||||
ILF | Ann: Change of Director's Interest Notice App | 12/06/12 | 0 | 781 | |||
|
|||||||
ILF | Ann: New York Asset Sales | 07/06/12 | 17 | 7.4K | |||
|
|||||||
ILF | Ann: Joint Company Secretary Appointment | 06/06/12 | 0 | 777 | |||
|
|||||||
ILF | Ann: Ingenia Communities makes its first acquisit | 06/06/12 | 0 | 1.7K | |||
|
|||||||
ILF | Ann: Ingenia Communities Fund - Consolidated Cons | 05/06/12 | 0 | 952 | |||
|
|||||||
ILF | Ann: Ingenia Communities Mgmt Trust - Consolidate | 05/06/12 | 0 | 884 | |||
|
|||||||
ILF | Ann: Initial Director's Interest Notice Appen | 05/06/12 | 0 | 677 | |||
|
See All Discussions